Literature DB >> 10749312

Perfluorocarbons and semifluorinated alkanes.

D Wong1, N Lois.   

Abstract

The introduction of perfluorocarbons (PFCs) and, more recently, semifluorinated alkanes (SFAs) has greatly facilitated vitreoretinal surgery. A distinction is made between the use of these substances as intraoperative tools and internal tamponade agents. This article reviews the physical and chemical properties of PFCs and SFAs and discusses the indications, results, and complications. The effectiveness of these substances as internal tamponade agents is discussed with reference to the specific gravity, contact angle, viscosity and ability to fill model eye chambers and the vitreous cavity. The evidence for the toxicity in animal and human is examined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749312     DOI: 10.3109/08820530009037848

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  10 in total

1.  A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting; Andrea Vento; Federica Cresti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

2.  Perfluorocarbon-perfused vitrectomy: a new method for vitrectomy--a safety and feasibility study.

Authors:  Hugo Quiroz-Mercado; J Guerrero-Naranjo; R Agurto-Rivera; C Leizaola-Fernández; L Suárez-Tatá; S Murillo-López; G Reategui-Escalante; G García-Aguirre; J Fromow-Guerra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

3.  Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia.

Authors:  Sebastian Wolf
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

4.  Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Andrea Vento; Federica Cresti; Sofia Miniaci; Maria Chiara Romagnoli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-01       Impact factor: 3.117

5.  Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber.

Authors:  C Wetterqvist; D Wong; R Williams; T Stappler; E Herbert; S Freeburn
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

6.  The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-21       Impact factor: 3.117

Review 7.  Biocompatibility of intraocular liquid tamponade agents: an update.

Authors:  Mario R Romano; Mariantonia Ferrara; Irene Nepita; Jana D'Amato Tothova; Alberto Giacometti Schieroni; Daniela Reami; Raniero Mendichi; Libero Liggieri; Rodolfo Repetto
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

Review 8.  Vitreous substitutes: the present and the future.

Authors:  Simone Donati; Simona Maria Caprani; Giulia Airaghi; Riccardo Vinciguerra; Luigi Bartalena; Francesco Testa; Cesare Mariotti; Giovanni Porta; Francesca Simonelli; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

Review 9.  Tamponade or filling effect: changes of forces in myopic eyes.

Authors:  Francesco Semeraro; Francesco Morescalchi; Andrea Russo; Mario R Romano; Ciro Costagliola
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

10.  Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome.

Authors:  Matthias Otto; Jörg Krebs; Peter Welker; René Holm; Manfred Thiel; Luciano Gattinoni; Michael Quintel; Charalambos Tsagogiorgas
Journal:  Pharmaceutics       Date:  2021-03-23       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.